- call +1-201-465-4211
- email sales@mrinsights.biz
A nucleic acid test (NAT) or nucleic acid amplification test (NAAT) is a technique utilized to detect a particular nucleic acid, virus, or bacteria which acts as a pathogen in blood, tissue, urine, etc. The NAT system differs from other tests in that it detects genetic materials rather than antigens or antibodies. Detection of genetic materials allows an early diagnosis of a disease because the detection of antigens requires time for antigens to appear in the bloodstream.
Scope of the Report:
This report studies the Nucleic Acid Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nucleic Acid Testing market by product type and applications/end industries.
According to the analysts, eminent factors like the higher adoption rate of molecular point-of-care (POC) testing will aid in the strong growth of this market during the forecast period. POC testing provides immediate results in non-laboratory settings to support more patient-centered approaches to healthcare delivery. The sensory technology enables the rapid analysis of blood samples. In the molecular diagnosis field, there is a higher adoption for POC testing systems as it helps in glucose self-testing.
The global Nucleic Acid Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nucleic Acid Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche
Becton
Dickinson and Company
Beckman Coulter
Abbott Laboratories
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Target Amplification Systems
Probe Amplification Systems
Signal Amplification
Market Segment by Applications, can be divided into
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Nucleic Acid Testing Market Overview
1.1 Product Overview and Scope of Nucleic Acid Testing
1.2 Classification of Nucleic Acid Testing by Types
1.2.1 Global Nucleic Acid Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Nucleic Acid Testing Revenue Market Share by Types in 2017
1.2.3 Target Amplification Systems
1.2.4 Probe Amplification Systems
1.2.5 Signal Amplification
1.3 Global Nucleic Acid Testing Market by Application
1.3.1 Global Nucleic Acid Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Infectious Diseases
1.3.3 Cancer
1.3.4 Personalized Medicine
1.3.5 Genetic and Mitochondrial Disorders
1.4 Global Nucleic Acid Testing Market by Regions
1.4.1 Global Nucleic Acid Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Nucleic Acid Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nucleic Acid Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nucleic Acid Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Nucleic Acid Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nucleic Acid Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Nucleic Acid Testing (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Nucleic Acid Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Becton
2.2.1 Business Overview
2.2.2 Nucleic Acid Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dickinson and Company
2.3.1 Business Overview
2.3.2 Nucleic Acid Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dickinson and Company Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Beckman Coulter
2.4.1 Business Overview
2.4.2 Nucleic Acid Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beckman Coulter Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Nucleic Acid Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Illumina
2.6.1 Business Overview
2.6.2 Nucleic Acid Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Illumina Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Siemens Healthineers
2.7.1 Business Overview
2.7.2 Nucleic Acid Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Siemens Healthineers Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 bioMerieux
2.8.1 Business Overview
2.8.2 Nucleic Acid Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 bioMerieux Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Nucleic Acid Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bio-Rad Laboratories
2.10.1 Business Overview
2.10.2 Nucleic Acid Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bio-Rad Laboratories Nucleic Acid Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Nucleic Acid Testing Market Competition, by Players
3.1 Global Nucleic Acid Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Nucleic Acid Testing Players Market Share
3.2.2 Top 10 Nucleic Acid Testing Players Market Share
3.3 Market Competition Trend
4 Global Nucleic Acid Testing Market Size by Regions
4.1 Global Nucleic Acid Testing Revenue and Market Share by Regions
4.2 North America Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
4.5 South America Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
5 North America Nucleic Acid Testing Revenue by Countries
5.1 North America Nucleic Acid Testing Revenue by Countries (2013-2018)
5.2 USA Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
6 Europe Nucleic Acid Testing Revenue by Countries
6.1 Europe Nucleic Acid Testing Revenue by Countries (2013-2018)
6.2 Germany Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
6.3 UK Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
6.4 France Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Nucleic Acid Testing Revenue by Countries
7.1 Asia-Pacific Nucleic Acid Testing Revenue by Countries (2013-2018)
7.2 China Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
7.5 India Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
8 South America Nucleic Acid Testing Revenue by Countries
8.1 South America Nucleic Acid Testing Revenue by Countries (2013-2018)
8.2 Brazil Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Nucleic Acid Testing by Countries
9.1 Middle East and Africa Nucleic Acid Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Nucleic Acid Testing Revenue and Growth Rate (2013-2018)
10 Global Nucleic Acid Testing Market Segment by Type
10.1 Global Nucleic Acid Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Nucleic Acid Testing Market Forecast by Type (2018-2023)
10.3 Target Amplification Systems Revenue Growth Rate (2013-2023)
10.4 Probe Amplification Systems Revenue Growth Rate (2013-2023)
10.5 Signal Amplification Revenue Growth Rate (2013-2023)
11 Global Nucleic Acid Testing Market Segment by Application
11.1 Global Nucleic Acid Testing Revenue Market Share by Application (2013-2018)
11.2 Nucleic Acid Testing Market Forecast by Application (2018-2023)
11.3 Infectious Diseases Revenue Growth (2013-2018)
11.4 Cancer Revenue Growth (2013-2018)
11.5 Personalized Medicine Revenue Growth (2013-2018)
11.6 Genetic and Mitochondrial Disorders Revenue Growth (2013-2018)
12 Global Nucleic Acid Testing Market Size Forecast (2018-2023)
12.1 Global Nucleic Acid Testing Market Size Forecast (2018-2023)
12.2 Global Nucleic Acid Testing Market Forecast by Regions (2018-2023)
12.3 North America Nucleic Acid Testing Revenue Market Forecast (2018-2023)
12.4 Europe Nucleic Acid Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Nucleic Acid Testing Revenue Market Forecast (2018-2023)
12.6 South America Nucleic Acid Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Nucleic Acid Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Nucleic Acid Testing Picture
Table Product Specifications of Nucleic Acid Testing
Table Global Nucleic Acid Testing and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
